RxDoctor Payments Data

Keith Wright, MD

Family Medicine · Manhattan, KSNPI 1174562227

Payments from drug & device makers

$3,992in general payments, 2019–2025

Across 288 payments — averaging $13.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$851
  • Pfizer$447
  • Amgen$407
  • Novo Nordisk$362
  • Takeda Pharmaceuticals U.S.A., Inc.$206
  • AstraZeneca$204
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$3,992100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,992 in reported general payments places this provider in the 85th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$550
Medicare patients
13
Services billed
738

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban32$26,642
JardianceEmpagliflozin30$19,839
FarxigaDapagliflozin Propanediol13$16,152
TradjentaLinagliptin25$13,907
XareltoRivaroxaban17$9,437
Repatha SyringeEvolocumab13$7,153
MyrbetriqMirabegron20$5,269
SynthroidLevothyroxine Sodium25$2,113
Levothyroxine Sodium197$1,332
Atorvastatin Calcium178$1,323
Losartan Potassium116$850
Omeprazole104$704
Escitalopram Oxalate63$586
Pantoprazole Sodium55$549
Duloxetine Hcl17$544

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$195$33,74655 claims
PfizerEliquis$447$26,64232 claims
AstraZenecaFarxiga$204$16,15213 claims
Johnson & JohnsonXarelto$111$9,43717 claims
Astellas Pharma US IncMyrbetriq$65$5,26920 claims
AbbVieSynthroid$851$2,11325 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Manhattan

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →